Skip to main content
OpenTrials

Clinical trial condition

TDP-43 Proteinopathies

Explore clinical trials studying TDP-43 Proteinopathies. Study availability and eligibility vary by location and protocol.

885 public trials 210 recruiting studies
Refine in advanced search Browse all conditions

TDP-43 Proteinopathies trial results

Completed

Single-Ascending-Dose Safety/Tolerability of NP001 in Amyotrophic Lateral Sclerosis (ALS)

NCT01091142

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • California Pacific Medical Center San Francisco, California, United States
  • University of Kansas Medical Center - Landon Center on Aging Kansas City, Kansas, United States
  • Department of Neurology; University of Kentucky Medical Center Lexington, Kentucky, United States
View Trial Details
Completed

Growth Hormone in Amyotrophic Lateral Sclerosis

NCT00635960

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • Diparimento di Scienze Neurologiche Naples, Italy
  • Istituto Biostrutture e Bioimmagini, Consiglio Nazionale delle Ricerche Naples, Italy
View Trial Details
Completed

Safety Study of Oral Sodium Phenylbutyrate in Subjects With ALS (Amyotrophic Lateral Sclerosis)

NCT00107770

Conditions
Amyotrophic Lateral Sclerosis, Central Nervous System Diseases, Metabolic Diseases, +8 more
Locations
  • VA Medical Center, Iowa City Iowa City, Iowa, United States
  • VA Medical Center, Lexington Lexington, Kentucky, United States
  • VA Maryland Health Care System, Baltimore Baltimore, Maryland, United States
  • Edith Nourse Rogers Memorial Veterans Hospital, Bedford Bedford, Massachusetts, United States
View Trial Details

Related conditions